Chiew H. Kong
Lister Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chiew H. Kong.
Blood Purification | 2003
Chiew H. Kong; Ken Farrington
Aim: To identify factors contributing to the development and progression of left ventricular hypertrophy (LVH) in patients on high-flux haemodialysis. Method: Fifty patients without clinical cardiac disease underwent baseline echocardiography, related measurements and follow-up studies 6–12 months later. Results: Residual urea clearance was lower (0.7 ± 1.1 vs. 2.2 ± 2.4 ml/min; p = 0.034) while systolic blood pressure (162 ± 21 vs. 147 ± 11 mm Hg; p = 0.003), duration of dialysis dependence (38 ± 37 vs. 17 ± 13 months; p = 0.004) and interdialytic weight gain (1.98 + 0.84 vs. 1.32 + 1.08 kg; p = 0.026) were higher in those with LVH. Parathyroid hormone changed less in those whose LVH regressed (186 ± 89 vs. 303 ± 280 pg/ml; p = 0.032). Regression did not occur when parathyroid hormone was >300 pg/ml. ACE gene polymorphism did not affect LVH development or progression. Conclusion: Systolic hypertension, duration of dialysis dependence and high interdialytic weight gains promote LVH. Hyperparathyroidism retards LVH regression.
Nephron | 2002
Chiew H. Kong; Ken Farrington
Accessible online at: www.karger.com/journals/nef Dear Sir, Our efforts to increase the efficiency of the dialysis process have, so far, focussed on what happens within the dialyser. Augmenting such parameters as blood and dialysis fluid flowrates and dialyser surface area enhances small solute clearance. [1, 2] The hitherto neglected aspect is that the real membrane exchange area is not within the dialyser but within the microcirculation. Even using optimised dialysis parameters, the achieved Kt/V during a dialysis session falls short of its potential because of solute rebound. The discrepancy is greater the shorter and more powerful the dialysis. Apart from the equilibration lag due to the molecular size, the dialysis process may induce vasoconstriction due the changes in the concentration of electrolytes. Thus the correction of raised levels of hydrogen, potassium and magnesium ions may cause the pre-capillary sphincters to constrict thereby reducing access to the exchange surface area. This would explain why the urea rebound is higher when a low dialysate (K+) is used [3]. A cool dialysate would lower body temperature in turn producing further vasoconstriction. At rest the capillaries are mostly collapsed further limiting the exchange between the intravascular and the intracellular compartments. This exchange is essential for the removal of solutes if we are concerned with not just clearance from the blood but also from the tissues particularly the muscles. It is not surprising that our average dialysis patient who is cold and lying still, but otherwise haemodynamically stable, is not getting the most out of dialysis in the given time. There are two levels of dialysis going on – at the capillary membrane and the dialyser membrane. The dialyser membrane will only clear as much as what is made available across the membrane between the intravascular and the intercellular compartments. Exercise increases blood flow to the tissues (especially the muscles where most of the solutes are stored) thereby opening up the latent exchange surface area. It has been shown that exercising during dialysis can reduce the rebound of urea, creatinine and potassium [4]. An hour of cycling during a 3–4 h dialysis increased the equilibrated urea KT/V by 14%, which is equivalent to an extra 20 min of dialysis. Just as important patients report that they feel good at the end of dialysis. This beneficial effect of exercise deserves consideration when planning a patient’s dialysis. Given the pressure to dialyse more patients and to deliver a higher KT/V [5] within the economic constraints it would make sense to capitalise on this. References
Nephrology Dialysis Transplantation | 1999
Chiew H. Kong; J. E. Tattersall; Roger Greenwood; Ken Farrington
Nephrology Dialysis Transplantation | 1999
Lu Kissmeyer; Chiew H. Kong; John Cohen; Robert J. Unwin; Robin G. Woolfson; Guy H. Neild
Nephrology Dialysis Transplantation | 2004
Anindya Banerjee; Chiew H. Kong; Ken Farrington
Blood Purification | 2003
Takahiro Kuragano; Tsutomu Kuno; Yoshiko Takahashi; Chii Yamamoto; Yuji Nagura; Susumu Takahashi; Katsuo Kanmatsuse; E.H.M. Loonen; Robert Zietse; W. Weimar; Rinaldo Bellomo; William Silvester; Louise Cole; I. C. van Riemsdijk; Carla C. Baan; Marco Malfanti; Ugo Zwahlen; Elena Pasotti; Giuseppe Colucci; Carlo Schönholzer; Chiew H. Kong; Ken Farrington; Tatsuya Nakatani; Kenji Tsuchida; Ontaku Fu; Kazunobu Sugimura; Yoshiaki Takemoto; Shigehiko Uchino; Hiroshi Morimatsu; Luca Gabutti
Blood Purification | 2003
Takahiro Kuragano; Tsutomu Kuno; Yoshiko Takahashi; Chii Yamamoto; Yuji Nagura; Susumu Takahashi; Katsuo Kanmatsuse; E.H.M. Loonen; Robert Zietse; W. Weimar; Rinaldo Bellomo; William Silvester; Louise Cole; I. C. van Riemsdijk; Carla C. Baan; Marco Malfanti; Ugo Zwahlen; Elena Pasotti; Giuseppe Colucci; Carlo Schönholzer; Chiew H. Kong; Ken Farrington; Tatsuya Nakatani; Kenji Tsuchida; Ontaku Fu; Kazunobu Sugimura; Yoshiaki Takemoto; Shigehiko Uchino; Hiroshi Morimatsu; Luca Gabutti